SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of May 21
 -1.30 / -0.55%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+0.10% 3 years+44.05%
3 months+9.31% 5 years+33.49%
1 year+83.36% Since inception+18.43%
Data through 05/20/2015

Quote Details

Previous close$234.74
Open day’s range-- – --
Net asset value (NAV)230.99 (05/19/2015)
Daily volume859,242
Average volume (3 months)1,004,004
Data as of 05/21/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+33.49%+22.89%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.121.46
Net assets$2.0B$1.7B
Average market cap$2.1B$35.4B
Average P/E--24.6
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
DYAX Dyax Corp1.56%
ESPR Esperion Therapeutics Inc1.44%
-- 1.44%
MNTA Momenta Pharmaceuticals Inc1.32%
INO Inovio Pharmaceuticals Inc1.31%
PRTA Prothena Corporation PLC1.27%
BLUE bluebird bio Inc1.25%
INCY Incyte Corp1.22%
FOLD Amicus Therapeutics Inc1.22%
REGN Regeneron Pharmaceuticals1.20%

To view my watchlist

Not a member yet?

Sign up now for a free account